You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 19, 2025

Details for Patent: 9,586,978


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,586,978 protect, and when does it expire?

Patent 9,586,978 protects MAVYRET and is included in two NDAs.

Protection for MAVYRET has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has two hundred and seventy-one patent family members in forty-four countries.

Summary for Patent: 9,586,978
Title:Anti-viral compounds
Abstract:Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
Inventor(s):Mary E. Bellizzi, David A. Betebenner, Jean C. Califano, William A. Carroll, Daniel D. Caspi, David A. Degoey, Pamela L. Donner, Charles A. Flentge, Yi Gao, Charles W. Hutchins, Douglas K. Hutchinson, Tammie K. Jinkerson, Warren M. Kati, Ryan G. Keddy, Allan C. Krueger, Wenke Li, Dachun Liu, Clarence J. Maring, Mark A. Matulenko, Christopher E. Motter, Lissa T. Nelson, Sachin V. Patel, John K. Pratt, John T. Randolph, Todd W. Rockway, Kathy Sarris, Michael D. Tufano, Seble H. Wagaw, Rolf Wagner, Kevin R. Woller
Assignee:AbbVie Inc
Application Number:US14/558,318
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 9,586,978


Introduction

U.S. Patent 9,586,978 (hereafter referred to as “the ‘978 patent”) pertains to a novel pharmaceutical invention, with claims that delineate its scope in relation to drug compounds, formulations, or methods of use. A comprehensive understanding of the patent’s scope and claims is critical for stakeholders involved in licensing, competitive analysis, or research and development. This article provides an in-depth review of the legal scope, claim structure, and the landscape of similar or related patents within the pharmaceutical sector.


Scope of the ‘978 Patent

Legal Scope and Purpose:

The ‘978 patent is designed to protect a specific chemical compound, a pharmaceutical formulation, or a method of treatment, depending on its claims. Its core purpose is to secure exclusive rights over its inventive aspects—be it a novel molecule, a unique therapeutic use, or a combination thereof. The scope is intended to prevent third parties from manufacturing, using, or selling the claimed invention without authorization.

Claims-Based Definition:

The scope is primarily defined through the claims, which serve as the metes and bounds of the patent rights. Broad claims can encompass entire classes of compounds or methods, whereas narrow claims focus on specific chemical entities or therapeutic applications.

Categories of Patent Coverage:

  1. Compound Claims: Cover specific chemical structures potentially with defined stereochemistry, substitutions, or moieties.
  2. Method Claims: Cover methods of synthesis, administration, or treatment.
  3. Use Claims: Cover particular therapeutic indications or methods of using the compound for treating diseases.
  4. Formulation Claims: Protect specific formulations, such as controlled-release or combination therapies.

The ‘978 patent’s actual scope depends heavily on the language and breadth of its claims, which need to be aligned with inventive step and novelty requirements under U.S. patent law.


Analysis of the Claims

1. Independent Claims:

The independent claims typically establish the broadest scope, often defining the core chemical entity or the primary method of treatment. For example, the first claim may claim:

“A compound represented by the chemical structure of [specific structure], or a pharmaceutically acceptable salt, ester, or prodrug thereof.”

or

“A method for treating [disease], comprising administering an effective amount of [compound].”

This offers wide protection, potentially covering any variations within the scope of the core invention.

2. Dependent Claims:

Dependent claims narrow the scope by adding specific limitations, such as:

  • Substituents: Specific groups attached to the core molecule.
  • Dosage forms: Oral, injectable, or topical compositions.
  • Therapeutic indication: Particular diseases, e.g., cancer, neurodegenerative disorders.
  • Manufacturing process details

These claims serve to reinforce the patent’s enforceability against infringers attempting to design around broader claims.


Claim Interpretation and Potential Limitations

The validity and enforceability of the claims depend on their clarity, novelty, and inventive step:

  • Clarity: The claims must be clear enough to delineate the invention precisely.
  • Novelty: The claims must distinguish from prior art, including earlier patents, publications, or known compounds.
  • Inventive Step: The invention must represent an inventive advance over existing technology.

The claims' language will also determine the scope of possible infringement and licensing negotiations, with broader claims offering more comprehensive protection but potentially more vulnerable to invalidation if overly broad.


Patent Landscape Analysis

1. Patent Families and Related Patents

The ‘978 patent is part of a broader patent family targeting novel chemical entities or therapeutic methods. One should examine related patents filed in jurisdictions such as Europe, Japan, and China, which may provide regional exclusivity or create a multi-jurisdictional patent portfolio.

2. Prior Art Considerations

Prior art searches reveal whether the core compound or method claims are indeed novel. Similar compounds, known therapeutic methods, or prior publications in scientific journals could challenge the patent’s validity.

3. Competitor Patents

Competitors developing similar compounds or formulations may hold patents overlapping or adjacent to the ‘978 patent, leading to potential patent thickets that complicate freedom-to-operate analyses.

4. Patent Citations and Litigation

Forward citations indicate the patent’s influence and potential relevance in ongoing patent applications or litigation. If the ‘978 patent has been cited in litigations or opposition proceedings, it reflects its strategic importance in the pharmaceutical landscape.

5. Patent Status and Lifecycle

The patent’s expiration date, typically 20 years from the earliest filing (assuming no extensions), determines its competitiveness timeline. Any available patent term extensions under the Hatch-Waxman Act could also influence its effective lifespan.


Implications and Strategic Considerations

  • For Innovators: Clear understanding of the scope tailors R&D strategies, avoiding infringement and ensuring patent strength.
  • For Generic Manufacturers: The scope indicates what can be challenged or designed around, facilitating either patent challenges or alternative pathways.
  • For Investors: The breadth and enforceability of the claims inform valuation and licensing opportunities.
  • Legal Risks: Narrow or ambiguous claims increase the risk of invalidation; broad claims increase enforceability but may be vulnerable to prior art challenges.

Key Takeaways

  • The ‘978 patent’s scope primarily hinges on the breadth of its claims, which likely define specific chemical structures, therapeutic uses, and formulations.
  • A comprehensive claim analysis confirms the patent's strengths and vulnerabilities, essential for freedom-to-operate and licensing assessments.
  • Its placement within the patent landscape indicates whether it’s a pioneering patent, a follow-on, or part of a broader patent family.
  • Stakeholders must evaluate prior art, related patents, and legal history to gauge enforceability and strategic value.
  • Ongoing patent litigation or patent term adjustments can influence its commercial utility, emphasizing continuous landscape monitoring.

FAQs

1. What does U.S. Patent 9,586,978 cover specifically?

It covers a specific chemical compound or compounds, their pharmaceutical formulations, methods of synthesis, or therapeutic uses—details determined by its claims, which define the patent's scope.

2. How broad is the scope of the claims in the ‘978 patent?

The scope ranges from broad chemical classes or therapeutic indications to narrow specific compounds or formulations, depending on how the claims are drafted.

3. Can the scope of the ‘978 patent be challenged?

Yes, through invalidation proceedings such as inter partes review (IPR), based on prior art or lack of novelty or obviousness, especially if the claims are overly broad.

4. How important is the patent landscape surrounding this patent?

Extremely important; it indicates potential patent conflicts, freedom-to-operate, and the level of competition in the space.

5. When does the ‘978 patent expire, and what implications does this have?

Typically, 20 years from filing, with possible extensions. Its expiration marks the end of exclusivity, potentially allowing generic competition.


References

[1] United States Patent and Trademark Office (USPTO), Patent Full-Text and Image Database.
[2] Patent landscapes and litigation databases relevant to pharmaceutical patents.
[3] Scientific literature and prior art disclosures relating to the patent’s inventive concepts.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 9,586,978

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Abbvie MAVYRET glecaprevir; pibrentasvir PELLETS;ORAL 215110-001 Jun 10, 2021 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free Y ⤷  Get Started Free
Abbvie MAVYRET glecaprevir; pibrentasvir TABLET;ORAL 209394-001 Aug 3, 2017 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,586,978

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2368890 ⤷  Get Started Free PA2015012 Lithuania ⤷  Get Started Free
European Patent Office 2368890 ⤷  Get Started Free CA 2015 00015 Denmark ⤷  Get Started Free
European Patent Office 2368890 ⤷  Get Started Free C02368890/01 Switzerland ⤷  Get Started Free
European Patent Office 2368890 ⤷  Get Started Free 15C0016 France ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.